CeloNova announces interim results from randomized controlled trial evaluating 14-days DAPT in complex patients at high bleeding risk following PCI

Press/Media

Period20 Oct 2020

Media coverage

1

Media coverage

  • TitleCeloNova announces interim results from randomized controlled trial evaluating 14-days DAPT in complex patients at high bleeding risk following PCI
    Media name/outletPharmaBiz
    Country/TerritoryIndia
    Date20/10/20
    PersonsRoxana Mehran,
View all 1
View less